Cite

HARVARD Citation

    Goldman, J. et al. (n.d.). Neratinib efficacy in patients with EGFR exon 18-mutant non-small-cell lung cancer: findings from the SUMMIT basket trial. European journal of cancer. pp. S82-. [Online]. 
  
Back to record